MENU

Eureka projects

Natural human monoclonal antibodies against Fibroblast Activation Protein to treat multiple myeloma

Raising the productivity and competitiveness of European businesses through technology. Boosting national economies on the international market, and strengthening the basis for sustainable prosperity and employment.